Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127903841 | 12790384 | 1 | I | 20160910 | 20160924 | 20160928 | 20160928 | PER | US-ASTRAZENECA-2016SF02678 | ASTRAZENECA | 24588.00 | DY | F | Y | 83.90000 | KG | 20160929 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127903841 | 12790384 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 73050 | UG | AZ160018 | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||
| 127903841 | 12790384 | 2 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 50.0MG UNKNOWN | 0 | 50 | MG | TABLET | |||||||
| 127903841 | 12790384 | 3 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 30 UNITS ONCE DAILY | 0 | ||||||||||
| 127903841 | 12790384 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 1000 | MG | BID | ||||||||
| 127903841 | 12790384 | 5 | C | LATANOPROST. | LATANOPROST | 1 | Ophthalmic | ONE DROP IN EACH EYE AT NIGHT | 0 | ||||||||||
| 127903841 | 12790384 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 50 | UG | QD | ||||||||
| 127903841 | 12790384 | 7 | C | REMERON | MIRTAZAPINE | 1 | Oral | 0 | 45 | MG | QD | ||||||||
| 127903841 | 12790384 | 8 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 60 | MG | QD | ||||||||
| 127903841 | 12790384 | 9 | C | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 0 | 4 | MG | BID | ||||||||
| 127903841 | 12790384 | 10 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 80 | MG | QD | ||||||||
| 127903841 | 12790384 | 11 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 0 | 200 | MG | BID | ||||||||
| 127903841 | 12790384 | 12 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 127903841 | 12790384 | 13 | C | NITROSTAT | NITROGLYCERIN | 1 | Sublingual | UNKNOWN, AS REQUIRED | 0 | ||||||||||
| 127903841 | 12790384 | 14 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 0 | 1000 | IU | BID | ||||||||
| 127903841 | 12790384 | 15 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 0 | 500 | UG | BID | ||||||||
| 127903841 | 12790384 | 16 | C | FISH OIL | FISH OIL | 1 | Oral | UNKNOWN, DAILY | 0 | ||||||||||
| 127903841 | 12790384 | 17 | C | PROBIOTIC | PROBIOTICS NOS | 1 | Oral | 10 BILLION CFU ONCE DAILY | 0 | ||||||||||
| 127903841 | 12790384 | 18 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 0 | 1000 | MG | BID | ||||||||
| 127903841 | 12790384 | 19 | C | FIBER SUPPLEMENT | 2 | Oral | 0 | 500 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127903841 | 12790384 | 1 | Type 2 diabetes mellitus |
| 127903841 | 12790384 | 2 | Stent placement |
| 127903841 | 12790384 | 3 | Type 2 diabetes mellitus |
| 127903841 | 12790384 | 4 | Type 2 diabetes mellitus |
| 127903841 | 12790384 | 5 | Eye disorder |
| 127903841 | 12790384 | 6 | Thyroid disorder |
| 127903841 | 12790384 | 7 | Fibromyalgia |
| 127903841 | 12790384 | 8 | Fibromyalgia |
| 127903841 | 12790384 | 9 | Muscle relaxant therapy |
| 127903841 | 12790384 | 10 | Blood cholesterol increased |
| 127903841 | 12790384 | 11 | Blood magnesium decreased |
| 127903841 | 12790384 | 12 | Stent placement |
| 127903841 | 12790384 | 13 | Cardiac disorder |
| 127903841 | 12790384 | 14 | Vitamin D deficiency |
| 127903841 | 12790384 | 15 | Vitamin B12 deficiency |
| 127903841 | 12790384 | 16 | Cardiac disorder |
| 127903841 | 12790384 | 17 | Dyspepsia |
| 127903841 | 12790384 | 18 | Vitamin supplementation |
| 127903841 | 12790384 | 19 | Gastrooesophageal reflux disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127903841 | 12790384 | Blood glucose increased | |
| 127903841 | 12790384 | Device issue | |
| 127903841 | 12790384 | Underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127903841 | 12790384 | 1 | 2006 | 0 | ||
| 127903841 | 12790384 | 2 | 2010 | 0 | ||
| 127903841 | 12790384 | 3 | 2006 | 0 | ||
| 127903841 | 12790384 | 4 | 2006 | 0 | ||
| 127903841 | 12790384 | 7 | 1995 | 0 | ||
| 127903841 | 12790384 | 8 | 2000 | 0 | ||
| 127903841 | 12790384 | 11 | 2014 | 0 | ||
| 127903841 | 12790384 | 12 | 2010 | 0 | ||
| 127903841 | 12790384 | 13 | 2010 | 0 | ||
| 127903841 | 12790384 | 14 | 2015 | 0 | ||
| 127903841 | 12790384 | 15 | 2015 | 0 | ||
| 127903841 | 12790384 | 16 | 2014 | 0 | ||
| 127903841 | 12790384 | 17 | 2014 | 0 | ||
| 127903841 | 12790384 | 18 | 2014 | 0 | ||
| 127903841 | 12790384 | 19 | 2014 | 0 |